Yahoo Web Search

Search results

    • Pfizer: An Oversold Pharma Stock in Recovery

      Pfizer: An Oversold Pharma Stock in Recovery

      GuruFocus.com via Yahoo Finance· 1 day ago

      It is a similar story for free cash flow, which is probably the main reason for the sell-off in 2023. At that time, shareholders feared the drop of FCF...